Catalyst Pharmaceuticals
CPRX
#3765
Rank
C$3.82 B
Marketcap
$32.05
Share price
-1.83%
Change (1 day)
72.45%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2024 (TTM): C$0.25 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are C$0.46 Billion. In 2023 the company made an earning of C$0.13 Billion a decrease over its 2022 earnings that were of C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.25 B89.49%
2023 C$0.13 B-9.75%
2022 C$0.14 B98.83%
2021 C$74.99 M25.73%
2020 C$59.64 M25.38%
2019 C$47.57 M-198.25%
2018 -C$48.42 Million84.68%
2017 -C$26.22 Million1.88%
2016 -C$25.74 Million-10.68%
2015 -C$28.81 Million30.46%
2014 -C$22.09 Million27.6%
2013 -C$17.31 Million198.17%
2012 -C$5.81 Million-36.22%
2011 -C$9.11 Million59.52%
2010 -C$5.71 Million-44.68%
2009 -C$10.32 Million-31.45%
2008 -C$15.05 Million155.21%
2007 -C$5.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$0.55 B 107.35%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.18 B-31.46%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.83 B 9,138.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.39 Billion-243.96%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.88 B 3,577.65%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.65 B 3,490.25%๐Ÿ‡บ๐Ÿ‡ธ USA